Author:
Chiriţoiu Gabriela N.,Munteanu Cristian V.A.,Şulea Teodor A.,Spiridon Laurenţiu,Petrescu Andrei-Jose,Jandus Camilla,Romero Pedro,Petrescu Ştefana M.
Funder
Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
Corporation for National and Community Service
Swiss National Science Foundation
Ontario Ministry of Research, Innovation and Science
Romanian Academy
Reference77 articles.
1. A new understanding in the epidemiology of melanoma;Erdei;Expert Rev. Anticancer Ther.,2010
2. Survival analysis in patients with cutaneous malignant melanoma;Radović-Kovacević;Srp. Arh. Celok. Lek.,1997
3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer;Topalian;N. Engl. J. Med.,2012
4. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer;Brahmer;N. Engl. J. Med.,2012
5. Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma;Raedler;Am. Health Drug Benefits,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献